AHA / ASA Scientific Statement Vascular Contributions to Cognitive Impairment and Dementia

By P. Gorelick, A. Scuteri, Sandra E. Black, C. DeCarli, S. Greenberg, C. Iadecola, Lenore J. Launer, S. Laurent, O. Lopez, D. Nyenhuis and 12 more. 2011

2,020 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Overview and Findings from the Rush Memory and Aging Project (2012, background): “This has important implications for our conceptuatlization of AD as well as vascular cognitive impairment [225].”
Vascular Contributions to Cognitive Impairment and Dementia Including Alzheimer’s Disease (2014, background): “A recent scientific statement from the American Heart Association (AHA) and American Stroke Association (ASA) highlighted the significance of vascular contributions to cognitive impairment and dementia (1), coined “VCID” here and referred to as vascular dementia and/or vascular cognitive impairment ”
Impact of multiple pathologies on the threshold for clinically overt dementia (2017, background): “Clinicians traditionally ascribe a specific etiology to the dementia syndrome for the obvious purpose of prognosis and management [40, 83, 84, 104, 107].”
Post-stroke cognitive impairment: epidemiology, mechanisms and management. (2014, background): “The recommendation for drug treatments of VCI from American Heart Association/ American Stroke Association (AHA/ASA) suggested that donepezil could be effective for cognitive enhancement in patients with VCI and be recommended with the Class IIa; Level A evidence (30).”